CD20 (Rituximab biosimilar) Antibody from ACROBIOSYSTEMS USA

Search, find, compare suppliers for anti-CD20 (Rituximab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD20 (Rituximab biosimilar)
Clonemonoclonal
Host SpeciesChimeric
Reactive Speciesn/a
IsotypeIgG1 kappa
Formatpurified
Size100ug
Concentrationn/a
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCD20 (Rituximab biosimilar). Rituximab biosimilar is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with CD20.
Immunogenn/a
Other Namesn/a
Gene, Accession #n/a
Catalog #CD0-M36-100ug
Price$150
Order / More InfoCD20 (Rituximab biosimilar) Antibody from ACROBIOSYSTEMS USA
Product Specific Referencesn/a
ACROBIOSYSTEMS USA
ACROBIOSYSTEMS USA
ACROBIOSYSTEMS USA
1 Innovation Way
Newark DE 19711
P: +1 800-810-0816
F: +1 888-377-6111

info@acrobiosystems.com

http://www.acrobiosystems.com

China Office:
ACROBIOSYSTEMS China
Room 109, No. 3 Disheng Middle St., BDA,
Beijing, 100176 China
Tel: +86 400-685-2052
Fax: +86 10-5885-0566


Profile of ACROBIOSYSTEMS USA
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.